Compare · GOOGL vs TEM
GOOGL vs TEM
Side-by-side comparison of Alphabet Inc. (GOOGL) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GOOGL and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- GOOGL is the larger of the two at $4.25T, about 342.8x TEM ($12.40B).
- Over the past year, GOOGL is up 36.8% and TEM is down 27.4% - GOOGL leads by 64.1 points.
- GOOGL has been more active in the news (13 items in the past 4 weeks vs 11 for TEM).
- Both have 25 recent analyst ratings on file.
- Company
- Alphabet Inc.
- Tempus AI Inc.
- Price
- $343.79-1.57%
- $66.15-7.01%
- Market cap
- $4.25T
- $12.40B
- 1M return
- -1.03%
- -17.65%
- 1Y return
- +36.76%
- -27.36%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2004
- 2024
- News (4w)
- 13
- 11
- Recent ratings
- 25
- 25
Alphabet Inc.
Alphabet Inc. provides online advertising services in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company offers performance and brand advertising services. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, such as ads, Android, Chrome, hardware, Google Maps, Google Play, Search, and YouTube, as well as technical infrastructure; and digital content. The Google Cloud segment offers infrastructure and data analytics platforms, collaboration tools, and other services for enterprise customers. The Other Bets segment sells internet and TV services, as well as licensing and research and development services. The company was founded in 1998 and is headquartered in Mountain View, California.
Latest GOOGL
- Alphabet Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Alphabet Inc. Securities Lawsuit - Contact Levi & Korsinsky
- SEC Form 4 filed by Alphabet Inc.
- Contracted Capacity Becomes Key Metric for AI Infrastructure Investors to Watch
- Fusion’s Prove-It Era Just Delivered a World-First Result
- XREAL AURA Starts at $1,279, Bringing Wired XR Glasses with Android XR to Customers This Year
- Director Arnold Frances sold $28,257 worth of Class C Capital Stock (83 units at $340.45) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 19,076 units (SEC Form 4)
- President, Global Affairs, CLO Walker John Kent covered exercise/tax liability with 10,729 units of Class C Google Stock Units and converted options into 10,631 units of Class C Capital Stock, increasing direct ownership by 15% to 22,023 units (SEC Form 4) (tax withholding)
- VP, Chief Accounting Officer Saraci Marsida covered exercise/tax liability with 492 units of Class C Google Stock Units and converted options into 487 units of Class C Capital Stock, increasing direct ownership by 1,843% to 28,362 units (SEC Form 4) (withholding obligation)
- President and CIO Porat Ruth converted options into 10,631 units of Class C Capital Stock and covered exercise/tax liability with 10,729 units of Class C Google Stock Units, increasing direct ownership by 4,760% to 927,069 units (SEC Form 4) (tax liability)
- SVP, Chief Financial Officer Ashkenazi Anat covered exercise/tax liability with 10,247 units of Class C Google Stock Units and converted options into 10,154 units of Class C Capital Stock, increasing direct ownership by 808% to 150,661 units (SEC Form 4) (withholding tax)
Latest TEM
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Amendment: SEC Form S-4/A filed by Tempus AI Inc.
- Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- CEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- CEO and Chairman Lefkofsky Eric P sold $19,366,630 worth of shares (250,000 units at $77.47) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Tempus AI Inc.
- Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model